RecruitingNCT07038928

TReatment Approaches and bIomarkers preValence in bladdEr Cancer in RuSsian Federation

A Multicentre Observational Study on Treatment Approaches and HER2 Positive Status Prevalence in Different Stages of Bladder Cancer and PD-L1-positive Status in Metastatic Bladder Cancer in Russian Federation


Sponsor

AstraZeneca

Enrollment

600 participants

Start Date

Jun 30, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

A multicentre observational study on treatment approaches and HER2 positive status prevalence in different stages of bladder cancer and PD-L1-positive status in metastatic bladder cancer in Russian Federation


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study collects real-world data on how bladder cancer is diagnosed and treated across Russia, and looks for biomarkers (biological signals) in tumor tissue that may predict how well patients respond to treatment. **You may be eligible if...** - You are 18 years old or older - You have a confirmed diagnosis of urothelial bladder cancer at any stage (non-muscle-invasive, muscle-invasive, or metastatic) - You have had a tumor tissue biopsy that can be tested - You are willing to sign a consent form including permission for tumor tissue testing **You may NOT be eligible if...** - Your bladder cancer diagnosis was not recently confirmed as per study criteria - You do not have suitable tissue samples available - You are unable to attend the required follow-up visits Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(19)

Research Site

Arkhangelsk, Russia

Research Site

Barnaul, Russia

Research Site

Chelyabinsk, Russia

Research Site

Krasnodar, Russia

Research Site

Krasnoyarsk, Russia

Research Site

Makhachkala, Russia

Research Site

Moscow, Russia

Research Site

Moscow, Russia

Research Site

Nizhny Novgorod, Russia

Research Site

Novosibirsk, Russia

Research Site

Obninsk, Russia

Research Site

Omsk, Russia

Research Site

Saint Petersburg, Russia

Research Site

Saint Petersburg, Russia

Research Site

Tomsk, Russia

Research Site

Tyumen, Russia

Research Site

Ufa, Russia

Research Site

Ufa, Russia

Research Site

Yekaterinburg, Russia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07038928


Related Trials